Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2014 Sep 4;371(10):970-1.
doi: 10.1056/NEJMc1408400.

Simvastatin in moderate-to-severe COPD

Gerard J Criner, John E Connett, Helen Voelker
Comment

Simvastatin in moderate-to-severe COPD

Gerard J Criner et al. N Engl J Med. .
No abstract available

PubMed Disclaimer

Comment on

  • Simvastatin for the prevention of exacerbations in moderate-to-severe COPD.
    Criner GJ, Connett JE, Aaron SD, Albert RK, Bailey WC, Casaburi R, Cooper JA Jr, Curtis JL, Dransfield MT, Han MK, Make B, Marchetti N, Martinez FJ, Niewoehner DE, Scanlon PD, Sciurba FC, Scharf SM, Sin DD, Voelker H, Washko GR, Woodruff PG, Lazarus SC; COPD Clinical Research Network; Canadian Institutes of Health Research. Criner GJ, et al. N Engl J Med. 2014 Jun 5;370(23):2201-10. doi: 10.1056/NEJMoa1403086. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836125 Free PMC article. Clinical Trial.
  • Simvastatin in moderate-to-severe COPD.
    Egom EE. Egom EE. N Engl J Med. 2014 Sep 4;371(10):969. doi: 10.1056/NEJMc1408400. N Engl J Med. 2014. PMID: 25184879 No abstract available.
  • Simvastatin in moderate-to-severe COPD.
    Suissa S. Suissa S. N Engl J Med. 2014 Sep 4;371(10):969-70. doi: 10.1056/NEJMc1408400. N Engl J Med. 2014. PMID: 25184880 No abstract available.

MeSH terms

Substances

LinkOut - more resources